Prenetics’ IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements

Core Insights - IM8, a new premium supplements brand by Prenetics, has officially launched on November 18th, 2024, focusing on science-driven health solutions [1] - The collaboration with Mayo Clinic aims to develop evidence-based supplements targeting optimal nutrition, cellular rejuvenation, protein support, collagen health, muscle recovery, and overall well-being [2][3] Group 1: Collaboration Details - The partnership with Mayo Clinic is designed to merge IM8's innovation with Mayo Clinic's medical expertise to advance health and longevity [1][3] - Initial research from the collaboration has shown promising insights, indicating a strong potential for the initiative [3] Group 2: Product Development Focus - The supplements will be clinically researched and developed to meet high standards of science and efficacy, empowering individuals to manage their health confidently [2] - Contributions from Dr. Dawn Mussallem, a Mayo Clinic integrative oncologist, will guide the precise development of these health-focused supplements [3] Group 3: Company Overview - Prenetics is a leading health sciences company with a focus on consumer and clinical health, including initiatives like IM8 and a $200 million venture in multi-cancer early detection technologies [5] - The company emphasizes enhancing life through science, with various units synergistically contributing to its global health impact [5]